Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 May 2026 Feb 2026 Nov 2025 Aug 2025 Jun 2025 May 2025 Feb 2025
Revenue $211.2M $224.7M $209.2M $221.0M
Cost of Revenue $112.2M $118.0M $114.2M $110.7M
Gross Profit $99.0M $106.7M $95.0M $110.3M
Gross Margin 46.9% 47.5% 45.4% 49.9%
Operating Expenses
Research & Development $3.8M $4.6M $5.1M $4.5M
SG&A Expense $60.3M $65.2M $60.9M $55.8M
Operating Income $-3.3M $-5.4M $-16.1M $5.4M
Operating Margin -1.6% -2.4% -7.7% 2.4%
Interest Expense
Pretax Income $-20.3M $-20.4M $43.8M $-9.7M
Income Tax Expense $-3.3M $-4.4M $7.5M $1.2M
Net Income $-17.0M $-15.9M $36.3M $-10.9M
Net Margin -8.0% -7.1% 17.4% -4.9%
EPS (Basic) $-0.08 $-0.07 $0.17 $-0.05
EPS (Diluted) $-0.08 $-0.07 $0.17 $-0.05
Shares Outstanding (Basic) 218.1M 217.7M 217.7M 217.4M 217.2M 217.2M 217.0M 217.0M
Shares Outstanding (Diluted) 218.1M 217.7M 217.7M 217.4M 217.3M 217.2M 217.0M 217.0M
Dividends Per Share
← Newer Page 1 of 12 Older →